LB Pharmaceuticals is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of schizophrenia.
Our lead drug candidate is a second-generation antipsychotic and a potential first-in-class benzamide to enter the U.S. market. With robust clinical development underway and a focus on long-term patient outcomes, we aim to set a new standard of care for neuropsychiatric conditions.
Company Details
- Employees
- 18
- Founded
- -
- Address
- The Unmet Need For Treating Negative Symptoms
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://lbpharma.us/
Lb Pharmaceuticals Inc Questions
Lb Pharmaceuticals Inc's website is https://lbpharma.us/
Lb Pharmaceuticals Inc's LinkedIn profile is https://www.linkedin.com/company/lbpharma
Lb Pharmaceuticals Inc has
18 employees.
View email and phone details for 18
employees at Lb Pharmaceuticals Inc.
Lb Pharmaceuticals Inc's industry is
Biotechnology Research
Lb Pharmaceuticals Inc's top competitors are
Contineum Therapeutics,
Neumora,
Neumirna Therapeutics,
Solid Biosciences,
Lb Pharmaceuticals, Inc.,
Tenvie Therapeutics,
Marvel Biosciences Corp.,
Nervgen Pharma Corp.,
Vesper Bio,
Nuvie Bio.
Lb Pharmaceuticals Inc's categories are Biotechnology Research
Lb Pharmaceuticals Inc's founding year is 2015
